This application claims the priority benefit of Taiwan application serial no. 100117418, filed May 18, 2011. The entirety of the above-mentioned patent application is hereby incorporated by reference herein and made a part of this specification.
The disclosure relates to an extraction apparatus for extracting a biological substance.
Microalgae are one of the biological energy sources that have the potential to be developed. Microalgal lipids are sealed in cells and can be secreted from the cells by applying the developing gene and metabolic engineering technologies. In addition, it is feasible to rupture the cell wall of the microalgae and extract the lipids from the microalgae. Whether the microalgae can be the mainstream alternative energy source rests in the possibility of improving the extraction efficiency and the performance of extracting the lipids from the microalgae.
Extraction of the lipids from the microalgae is one of the liquid-solid extraction techniques and is achieved by means of a solvent. However, the solid microalgae are small, and after the cell walls of the microalgae are ruptured is 50 by weight at least. Hence, the solvent (e.g., hexane) that is not apt to be dissolved in the water is applied for liquid-solid extraction. On the other hand, when the solvent (e.g., methanol) having the similar polarity to that of the water is utilized for liquid-solid extraction, the solvent needs to be at least twice the microalgae, and thus the costs on separation of the solvent from the microalgae are rather high.
The disclosure is directed to an extraction apparatus in which an extraction solvent is applied to extract a biological substance in an efficient manner. For instance, when the extraction apparatus is applied to extract lipids from the microalgae, retention time between the microalgal lipids and the extraction solvent can be significantly increased, solubility of the microalgal lipids in the extraction solvent can be improved, and an impact of the water content of the microalgae on the extraction of the lipids from the microalgae can be lessened. Hence, the efficiency of extracting the lipids from the microalgae by using the extraction solvent can be enhanced.
Specifically, the extraction apparatus described in the exemplary embodiments of the disclosure has a chamber and includes a shaft, a plurality of rotation discs, a biological substance feeding entrance, an extraction solvent injection entrance, an extract outlet, a raffinate outlet, and a depositor. The shaft has a first end and a second end. The first end is adjacent to a top of the chamber, and the second end is adjacent to a bottom of the chamber. The rotation discs are juxtaposed at the first end of the shaft, and each of the rotation discs has at least one opening. The biological substance feeding entrance is located at the top of the chamber for introducing a biological substance to the opening of the uppermost rotation disc, such that the biological substance moves downward and sequentially passes through the opening of each of the rotation discs. The extraction solvent injection entrance located is at the bottom of the chamber. An extraction solvent is injected into the chamber through the extraction solvent injection entrance, such that the extraction solvent and the biological substance are reversely contacted to generate an extract and a raffinate. The extract outlet is located at the top of the chamber for discharging the extract. The raffinate outlet is located at the bottom of the chamber for discharging the raffinate. The depositor is configured at the second end of the shaft for collecting the raffinate and discharging the raffinate from the chamber through the raffinate outlet.
Several exemplary embodiments accompanied with figures are described in detail below to further describe the disclosure in details.
The accompanying drawings are included to provide a further understanding of the disclosure, and are incorporated in and constitute a part of this disclosure. The drawings illustrate embodiments of the disclosure and, together with the description, serve to explain the principles of the disclosure.
The feed unit 200 is connected to the biological substance feeding entrance 112, so as to provide the chamber 110 with the biological substance. In this exemplary embodiment, the feed unit 200 can include a cell rupture apparatus, such as a high-pressure homogenizer 210 or a ball miller, as shown in
The extraction solvent is stored in an extraction solvent storage unit 400, and the extraction solvent is injected into the chamber 110 of the extraction unit 100 through the extraction solvent injection entrance 118. A residue discharge valve 800 can be configured below the chamber 110 and connected to the raffinate outlet 116 that is located at the bottom of the chamber 110 for controlling the action of discharging the raffinate. A raffinate container 500 is placed below the extraction unit 100 for collecting the raffinate discharged from the raffinate outlet 116.
The separation unit 300 is connected to the extract outlet 114 for separating the extract from the extraction solvent and then collecting the extract and the extraction solvent. The separation unit 300 described in the exemplary embodiment of the disclosure can separate and recycle the extraction solvent due to the changeable solubility of the extract in the extraction solvent under different temperature or pressure, and the extraction solvent is re-introduced into the chamber 110 of the extraction unit 100 through another extraction solvent injection outlet 119. Thereby, the amount of the extraction solvent can be reduced.
With reference to
The extract enters the separation unit 300 shown in
In this exemplary embodiment, the shaft 120 passes through a center of each of the rotation discs 130, so as to rotate the rotation discs 130. Besides, each of the rotation discs 130 inclines down in a direction from the center to the peripheries of the disc 130. The guiding board 150 is configured between the rotation discs 130 and the depositor 140. The guiding board 150 includes a first portion 152 and a second portion 154. The first portion 152 is adjacent to and parallel to an inner wall of the chamber 110, and the second portion 154 is transversely configured in the chamber 110. The first portion 152 and the inner wall of the chamber 110 constitute a channel 190, and openings at two ends of the channel 190 are respectively adjacent to the extraction solvent injection entrances 118 and 119 and the lowermost rotation disc 130. Thereby, the extraction solvent injected from the extraction solvent injection entrances 118 and 119 can flow among the rotation discs 130 through the channel 190 and can be reversely contacted to the biological substance for generating the extract and the raffinate.
The location of the opening 132 on each of the rotation discs 130 of the extraction unit 100 can be adjusted according to this exemplary embodiment, so as to improve the extraction efficiency. To be more specific, the openings 132 of two adjacent rotation discs 130 can be overlapped or not overlapped in an extension direction L of the shaft 120. If the openings 132 of two adjacent rotation discs 130 are not overlapped, it means the opening 132 of each of the rotation discs 130 is alternately arranged. The biological substance and the extraction solvent flow among the rotation discs 130 along the inclination directions of the rotation discs 130 and flow through a large portion of the area among the rotation discs 130, as shown by the arrows in
Several types of the rotation discs applicable to this exemplary embodiment are enumerated hereinafter. For instance, the rotation disc 130A shown in
The rotation disc 130B shown in
The rotation disc 130C shown in
The rotation disc 130D shown in
Other structural parameters of the extraction unit 100 can also be designed in the exemplary embodiment to modify the manufacturing process. For instance, a distance between two adjacent rotation discs 130 ranges from about 0.1 mm to about 10 mm. A diameter of the opening 132 of each of the rotation discs 130 ranges from about 0.1 mm to about 10 mm. A distance between the inner wall of the chamber 110 and an edge of each of the rotation discs 130 ranges from about 0.01 mm to about 10 mm. An inclined angle θ between each of the rotation discs 130 and a horizontal direction ranges from about 1° to about 90°. Certainly, the rotation discs 130 are not limited to be circular and can be shaped in other way as long as similar effects can be achieved.
Besides, given that the length of the shaft 120 in the chamber 110 of the extraction unit 100 is 400 mm, for instance, the number of the rotation discs 130 ranges from 1 to 1000. However, if the length of the shaft 120 exceeds 400 mm, the number of the rotation discs 130 may also exceed 1000. That is to say, the number of the rotation discs 130 can be determined based on the length of the shaft 120 or the distance between two adjacent rotation discs 130. In most cases, the more the rotation discs 130, the better the extraction efficiency, and the less the amount of the extraction solvent.
On the other hand, both the shear force generated by rotating the rotation discs 130 and the changeable moving speed of the rotation discs 130 and pressure can further destruction of the cell wall of the biological substance, so as to enhance the cell rupture effects and improve the extraction efficiency correspondingly.
Additionally, the second portion 154 of the guiding board 150 collects the raffinate discharged from the opening 132 of the lowermost rotation disc 130 and guides the raffinate to the underlying depositor 140. As indicated in
The extraction apparatus 10 described in the previous exemplary embodiments can be applied to extract the lipids from the microalgae in the following fashion. The microalgae are introduced to the extraction unit 100 by using the feed unit 200. A cell rupture reagent including strong acid, strong alkali, a deposition solvent, and a cosolvent can be selectively added to the feed unit 200. Besides, a heat exchanger (not shown) can control the temperature at which the microalgae are introduced to the chamber 110, so as to improve the efficiency of extracting the microalgal lipids by using the extraction solvent. The microalgae are injected among the rotation discs 130 from the biological substance feeding entrance 112 and the openings 132 of the rotation discs 130 and flow among the rotation discs 130 due to the centrifugal force generated by rotating the rotation discs 130. Thereby, the microalgae can be mixed with the extraction solvent injected from the extraction solvent injection entrance 118 that is located at the bottom of the chamber 110, and the mixture can sequentially enter the lower rotation discs 130. The efficiency of extracting the microalgal lipids by using the extraction solvent can be improved because the mixture flows among the rotation discs 130. Besides, the water content of the microalgae can be separated and removed from the outer sides or the ends of the rotation discs 130 by using parts of the extraction solvent, so as to lessen the impact of the water content of the microalgae to lipids extraction.
The microalge discharged from the lowermost rotation disc 130 include water and microalgal residues. Due to the V-shaped discs 142 of the depositor (shown in
In light of the foregoing, the extraction apparatus described in the exemplary embodiments of the disclosure is capable of continuously and efficiently extracting the biological substance. Multiple rotation discs are utilized in the extraction apparatus to significantly improve the efficiency of extracting the biological substance by using the extraction solvent. Specifically, when the extraction solvent is applied to extract the lipids from the microalgae, the retention time of the microalgal lipids in the extraction solvent can be significantly increased, solubility of the microalgal lipids in the extraction solvent can be improved, and the impact of the water content of the microalge on the lipids extraction from the microalgae can be lessened. Hence, the efficiency of extracting the lipids from the microalgae by using the extraction solvent can be enhanced. On the other hand, owing to the improvement of the efficiency of extracting the lipids from the microalgae, the amount of the extraction solvent can be reduced, and production costs can be reduced.
It will be apparent to those skilled in the art that various modifications and variations can be made to the structure of the disclosed exemplary embodiments without departing from the scope or spirit of the disclosure. In view of the foregoing, it is intended that the disclosure cover modifications and variations of this disclosure provided they fall within the scope of the following claims and their equivalents.
Number | Date | Country | Kind |
---|---|---|---|
100117418 A | May 2011 | TW | national |
Number | Name | Date | Kind |
---|---|---|---|
3258964 | Zessoules | Jul 1966 | A |
5330913 | Nakayama | Jul 1994 | A |
5362895 | Engelhardt et al. | Nov 1994 | A |
5539133 | Kohn et al. | Jul 1996 | A |
5951875 | Kanel et al. | Sep 1999 | A |
6166231 | Hoeksema | Dec 2000 | A |
6405984 | Simons et al. | Jun 2002 | B1 |
6812001 | Sibeijn et al. | Nov 2004 | B2 |
7063855 | Hjaltason et al. | Jun 2006 | B2 |
7226771 | Gramatikova et al. | Jun 2007 | B2 |
7371343 | Kim | May 2008 | B2 |
7396548 | Kyle | Jul 2008 | B2 |
7648635 | Seidlitz et al. | Jan 2010 | B2 |
20020025548 | Sibeyn et al. | Feb 2002 | A1 |
20020055135 | Sibeijn et al. | May 2002 | A1 |
20030150804 | Haubs et al. | Aug 2003 | A1 |
20070003686 | Fichtali et al. | Jan 2007 | A1 |
20070196894 | Sim et al. | Aug 2007 | A1 |
20080038290 | Renimel et al. | Feb 2008 | A1 |
20080220515 | McCall | Sep 2008 | A1 |
20080226740 | Chen et al. | Sep 2008 | A1 |
20090298158 | Thomas et al. | Dec 2009 | A1 |
20090324799 | Hartman et al. | Dec 2009 | A1 |
20100041926 | Kang et al. | Feb 2010 | A1 |
20100080761 | Herrmann et al. | Apr 2010 | A1 |
20100124774 | Kim et al. | May 2010 | A1 |
20100143267 | Pertile et al. | Jun 2010 | A1 |
20100204315 | Okino et al. | Aug 2010 | A1 |
20100236137 | Wu et al. | Sep 2010 | A1 |
20100261918 | Chianelli et al. | Oct 2010 | A1 |
20100261922 | Fleischer et al. | Oct 2010 | A1 |
20100304452 | Oyler | Dec 2010 | A1 |
20110147305 | Marlow et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
1241149 | Jan 2000 | CN |
1408263 | Apr 2003 | CN |
1448383 | Oct 2003 | CN |
1544413 | Nov 2004 | CN |
101352249 | Jan 2009 | CN |
101368193 | Feb 2009 | CN |
101445496 | Jun 2009 | CN |
101485973 | Jul 2009 | CN |
101648955 | Feb 2010 | CN |
101736045 | Jun 2010 | CN |
101747924 | Jun 2010 | CN |
101748053 | Jun 2010 | CN |
101750460 | Jun 2010 | CN |
101774956 | Jul 2010 | CN |
101802206 | Aug 2010 | CN |
1197218 | Apr 2002 | EP |
60207567 | Oct 1985 | JP |
06106002 | Apr 1994 | JP |
200526713 | Aug 2005 | TW |
200904975 | Feb 2009 | TW |
200948390 | Dec 2009 | TW |
I322186 | Mar 2010 | TW |
201019943 | Jun 2010 | TW |
201041638 | Dec 2010 | TW |
2010090590 | Aug 2010 | WO |
Entry |
---|
M. Cygnarowicz-Provost et al., “Supercritical-Fluid Extraction of Fungal Lipids: Effect of Cosolvent on Mass-Transfer Rates and Process Design and Economics”, The Journal of Supercritical Fluids, 1995, 8, p. 51-59. |
P. Vauchel et al., “A New Process for Extracting Alginates from Laminaria digitata: Reactive Extrusion”, Food and Bioprocess Technology, Sep. 2008, vol. 1, No. 3: p. 1-6. |
A. Gimenez et al., “Downstream processing and purification of eicosapentaenoic (20:5n-3) and arachidonic acids (20:4n-6) from the microalga Porphyridium cruentum”, Bioseparation 7, 1998, p. 89-99. |
R. Halim et al., “Oil extraction from microalgae for biodiesel production” Bioresource Technology, 2010, p. 1-33. |
R. Eggers, “Large-Scale Industrial Plant for Extraction with Supercritical Gases”, Angew. Chem. Int. Ed. Engl., 17, 1978, p. 751-754. |
“Notice of Allowance of Taiwan Counterpart Application”, issued on Sep. 23, 2013, p1-p4. |
Number | Date | Country | |
---|---|---|---|
20120294777 A1 | Nov 2012 | US |